top of page
beige linen.png

Smart Cells – Curated Article List

Collected by Darcy
20 Peer-Reviewed Publications Indexed in PubMed

1. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty

Journal: J Gerontol A Biol Sci Med Sci (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/28977399/

PMID: 28977399

Note: Phase II Clinical Trial (Double-Blind, Randomized, Placebo-Controlled)

 

2. Global Position Paper on Cardiovascular Regenerative Medicine

Journal: Eur Heart J (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/28575280/

PMID: 28575280

Note: Extensive task force collaboration, no abstract available

 

3. Concise Review: Cell Dosage and Routes in Stem Cell Therapy for Heart Disease

Journal: Stem Cells Transl Med (2016)

DOI: https://pubmed.ncbi.nlm.nih.gov/26683870/

PMID: 26683870

 

4. Pregnancy, Parabiosis, and Peripartum Cardiomyopathy

Journal: Front Biosci (Landmark Ed) (2021)

DOI: https://pubmed.ncbi.nlm.nih.gov/34590475/

PMID: 34590475

 

5. Simulated Microgravity Impairs Cardiac Neurogenesis

Journal: Stem Cells Dev (2018)

DOI: https://pubmed.ncbi.nlm.nih.gov/29336212/

PMID: 29336212

 

6. Synergistic Effects of Combined Cell Therapy in Cardiomyopathy

Journal: J Am Coll Cardiol (2015)

DOI: https://pubmed.ncbi.nlm.nih.gov/26516002/

PMID: 26516002

 

7. Allogeneic Human MSC Infusions for Aging Frailty

Journal: J Gerontol A Biol Sci Med Sci (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/28444181/

PMID: 28444181

 

8. Effects of Aging on MSC Therapy in Cardiomyopathy

Journal: J Am Coll Cardiol (2015)

DOI: https://pubmed.ncbi.nlm.nih.gov/25593053/

PMID: 25593053

 

9. FDA Expanded Access for Cell Therapy in Rare Diseases

Journal: Front Cell Dev Biol (2021)

DOI: https://pubmed.ncbi.nlm.nih.gov/34169074/

PMID: 34169074

 

10. Genetic Predictors of Response in Non-Ischemic Cardiomyopathy

Journal: EBioMedicine (2019)

DOI: https://pubmed.ncbi.nlm.nih.gov/31648988/

PMID: 31648988

 

11. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial

Journal: J Am Coll Cardiol (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/27856208/

PMID: 27856208

Note: Clinical Trial

 

12. Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells

Journal: EBioMedicine (2015)

DOI: https://pubmed.ncbi.nlm.nih.gov/26137590/

PMID: 26137590

 

13. Transendocardial MSCs and Bone Marrow Cells for Ischemic Cardiomyopathy: TAC-HFT Trial

Journal: JAMA (2014)

DOI: https://pubmed.ncbi.nlm.nih.gov/24247587/

PMID: 24247587

Note: Clinical Trial

 

14. POSEIDON-DCM Study Design for Stem Cell Therapy in Cardiomyopathy

Journal: J Cardiovasc Transl Res (2014)

DOI: https://pubmed.ncbi.nlm.nih.gov/25354998/

PMID: 25354998

Note: Phase I/II Pilot Study

 

15. Dose Comparison of Allogeneic MSCs in Ischemic Cardiomyopathy (TRIDENT Study)

Journal: Circ Res (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/28923793/

PMID: 28923793

Note: Clinical Trial

 

16. Effect of MSC Injection on Ventricular Proarrhythmia in Cardiomyopathy

Journal: Stem Cells Transl Med (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/28252842/

PMID: 28252842

Note: Clinical Trial

 

17. Allogeneic MSCs for Idiopathic Pulmonary Fibrosis (AETHER Trial)

Journal: Chest (2017)

DOI: https://pubmed.ncbi.nlm.nih.gov/27890713/

PMID: 27890713

Note: Phase I Safety Trial

 

18. Design of CONCERT-HF Trial for Regenerative Therapy in Heart Failure

Journal: Circ Res (2018)

DOI: https://pubmed.ncbi.nlm.nih.gov/29703749/

PMID: 29703749

Note: Clinical Trial

 

19. Effect of Stem Cell Injection on Erectile Function in Men with Cardiomyopathy

Journal: J Sex Med (2020)

DOI: https://pubmed.ncbi.nlm.nih.gov/32059936/

PMID: 32059936

 

20. PROMETHEUS Trial: Autologous MSCs in CABG Patients

Journal: Circ Res (2014)

DOI: https://pubmed.ncbi.nlm.nih.gov/24565698/

PMID: 24565698

Note: Clinical Trial

bottom of page